Quick Links
SOLAI (SLAI) Receives NYSE Dual Non-Compliance Notice: Market Cap and Equity Both Below $50M Threshold
Data Snapshot
Key Takeaways
- •SLAI has breached both the NYSE $50M market cap AND $50M stockholders' equity thresholds simultaneously — a more serious condition than a price-only deficiency.
- •With market cap reported near US$14.76M, SOLAI must more than triple its valuation to reach the listing floor — a steep bar requiring meaningful corporate action or sector tailwind.
- •The company is already under a separate share-price non-compliance notice (<$1.00 ADS), meaning two active NYSE cure clocks are running concurrently.
- •ADSs remain tradeable during the cure period, but institutional mandates requiring main-board compliance could trigger forced selling.
- •The event is idiosyncratic — no systemic spillover to broader crypto markets, indices, or macro variables — but reinforces elevated risk across similar micro-cap crypto-infrastructure equities.

According to an SEC filing disclosure cited by GuruFocus and StockTitan, SOLAI Limited (NYSE: SLAI) — a technology-driven cryptocurrency infrastructure company formerly known as BTCM — has received a
Event Analysis
According to an SEC filing disclosure cited by GuruFocus and StockTitan, SOLAI Limited (NYSE: SLAI) — a technology-driven cryptocurrency infrastructure company formerly known as BTCM — has received a formal NYSE non-compliance notice for failing *two simultaneous* continued-listing thresholds: a 30-day average market capitalization below US$50M and last-reported stockholders' equity below US$50M. This triggers NYSE Section 802.01B procedures, giving SOLAI approximately 90 days to submit a business turnaround plan and, if accepted, up to an 18-month cure window. Critically, the ADSs continue to trade during this period.
This is SOLAI's second active NYSE compliance breach. The company separately disclosed a Section 802.01C share-price deficiency (ADS average below US$1.00 over 30 consecutive trading days) earlier in 2026, with its market capitalization reported at approximately US$14.76M at that time — roughly 70% below the US$50M continued-listing floor. As GuruFocus notes, the company faces "significant challenges in profitability and growth," underscoring that both notices reflect genuine balance-sheet weakness, not a statistical technicality. An independent director resignation and replacement occurred concurrently, adding governance uncertainty to an already stressed situation.
What separates this from a pure price-deficiency notice is the equity component: failing the stockholders' equity test signals that the balance sheet itself may be impaired, not merely that share-price momentum has faded. This raises the cost and dilution of any capital raise needed to cure the deficiency, making the path to compliance structurally harder. The parallel with issuers like Skillsoft and Trinseo — both granted 18-month cure windows under near-identical mechanics — suggests the procedural path is well-worn, but execution is not guaranteed.
For broader context, this event fits a recognizable pattern among micro-cap crypto-infrastructure equities that expanded during the 2020–2021 cycle and have since experienced severe valuation compression. SOLAI's annualized volatility is reported at 90.89 with a beta of 2.2, per GuruFocus, reflecting a stock that moves more than twice as aggressively as the broader market.
What This Means for Traders
For event-driven traders, SLAI now presents a binary-outcome, high-volatility micro-cap setup. The upside path requires SOLAI to submit a credible turnaround plan within ~90 days — potentially involving a reverse stock split, asset sales, strategic partnerships, or capital raises — and for NYSE to accept it. A strong crypto-market rally could organically lift the sector and push SLAI's market cap above US$50M, though at ~US$14.76M that gap is substantial. The downside path leads to NYSE suspension and OTC migration, which typically triggers institutional forced selling and severe liquidity compression.
Key watchpoints include: the content and timing of SOLAI's plan submission; any corporate action announcements (particularly a reverse split, which would also address the separate share-price notice); quarterly NYSE compliance reviews during the cure window; and broader crypto infrastructure sentiment. Traders interested in how listed companies manage bitcoin treasury strategy under distress will find SLAI instructive as a stress-case example. Monitoring NYSE's published non-compliant issuer list is a systematic way to identify similar setups across the micro-cap segment.
Volatility is expected to remain episodic — clustering around plan submission deadlines, NYSE responses, and any corporate action news. Liquidity is thin at micro-cap scale; borrow availability for short positions should be verified before execution. The event carries no systemic implications for the S&P 500 or NASDAQ 100.
Start Trading on CoinUnited.io
Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.
Frequently Asked Questions
Yes — NYSE ADSs continue to trade during both the plan-submission period and the cure window. Delisting only occurs if NYSE rejects the plan or SOLAI fails to demonstrate compliance progress within the cure period.
Continue Exploring
Disclaimer: This brief is for educational purposes only and is not investment advice.